HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹315 Cr | ₹294 Cr | ₹229 Cr | ₹285 Cr | ₹186 Cr |
What is the latest Cash Flow from Operating Activities ratio of HIKAL ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹315 Cr |
Mar2022 | ₹294 Cr |
Mar2021 | ₹229 Cr |
Mar2020 | ₹285 Cr |
Mar2019 | ₹186 Cr |
How is Cash Flow from Operating Activities of HIKAL Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹315 Cr | 7.35 | |
Mar2022 | ₹294 Cr | 28.26 | |
Mar2021 | ₹229 Cr | -19.62 | |
Mar2020 | ₹285 Cr | 53.53 | |
Mar2019 | ₹186 Cr | - |
Compare Cash Flow from Operating Activities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,667.6 Cr | -4.8% | 7.9% | 2.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -4.8% |
7.9% |
2.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses